Education
About Us
Working with TipRanks
Follow Us
Uipath Inc (PATH)
:PATH
PATH Analyst Ratings
Hold
3 Buy
16 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PATH Stock 12 Month Forecast
Average Price Target
$12.03
▲(11.29% Upside)
| Highest Price Target$15.00 | Average Price Target$12.03 | Lowest Price Target$10.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Oppenheimer
Reiterated
03/13/25
FBN Securities
Reiterated
03/13/25
BMO Capital
Reiterated
03/13/25
Evercore ISI
Reiterated
03/13/25
Truist Financial
Reiterated
03/13/25
J.P. Morgan
Reiterated
03/13/25
D.A. Davidson
Reiterated
03/13/25
KeyBanc
Reiterated
03/13/25
Barclays
Reiterated
03/13/25
Scotiabank
Reiterated
03/13/25
Bank of America Securities
$10
Sell
-7.49%
Downside
Downgraded
03/13/25
UiPath downgraded to Underperform from Neutral at BofAUiPath downgraded to Underperform from Neutral at BofA
Canaccord Genuity
$19→$14
Buy
29.51%
Upside
Reiterated
03/13/25
UiPath price target lowered to $14 from $19 at CanaccordUiPath price target lowered to $14 from $19 at Canaccord
UBS
$14→$10
Sell
-7.49%
Downside
Reiterated
03/13/25
UiPath price target lowered to $10 from $14 at UBSUiPath price target lowered to $10 from $14 at UBS
Morgan Stanley
$12
Hold
11.01%
Upside
Reiterated
03/13/25
UiPath's Financial Outlook Impacted by Delayed Deals and Conservative Growth Forecast Amidst Economic Challenges
William Blair
―
Hold
―
Reiterated
03/13/25
UiPath's Mixed Q4 Results and AI Demand Justify Hold Rating Amid Macroeconomic Challenges
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Oppenheimer
Reiterated
03/13/25
FBN Securities
Reiterated
03/13/25
BMO Capital
Reiterated
03/13/25
Evercore ISI
Reiterated
03/13/25
Truist Financial
Reiterated
03/13/25
J.P. Morgan
Reiterated
03/13/25
D.A. Davidson
Reiterated
03/13/25
KeyBanc
Reiterated
03/13/25
Barclays
Reiterated
03/13/25
Scotiabank
Reiterated
03/13/25
Bank of America Securities
$10
Sell
-7.49%
Downside
Downgraded
03/13/25
UiPath downgraded to Underperform from Neutral at BofAUiPath downgraded to Underperform from Neutral at BofA
Canaccord Genuity
$19→$14
Buy
29.51%
Upside
Reiterated
03/13/25
UiPath price target lowered to $14 from $19 at CanaccordUiPath price target lowered to $14 from $19 at Canaccord
UBS
$14→$10
Sell
-7.49%
Downside
Reiterated
03/13/25
UiPath price target lowered to $10 from $14 at UBSUiPath price target lowered to $10 from $14 at UBS
Morgan Stanley
$12
Hold
11.01%
Upside
Reiterated
03/13/25
UiPath's Financial Outlook Impacted by Delayed Deals and Conservative Growth Forecast Amidst Economic Challenges
William Blair
―
Hold
―
Reiterated
03/13/25
UiPath's Mixed Q4 Results and AI Demand Justify Hold Rating Amid Macroeconomic Challenges
Best Analysts Covering UiPath
Which Analyst Should I Follow If I Want to Buy PATH and Sell After:
1 Month
xxx
Success Rate
4/10 ratings generated profit
Average Return
+0.50%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of +0.50% per trade.
3 Months
xxx
Success Rate
6/10 ratings generated profit
Average Return
-1.87%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of -1.87% per trade.
1 Year
Success Rate
3/12 ratings generated profit
Average Return
-25.43%
downgraded a sell rating 13 days ago
Copying Bradley Sills's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -25.43% per trade.
2 Years
xxx
Success Rate
1/10 ratings generated profit
Average Return
-25.05%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 10.00% of your transactions generating a profit, with an average return of -25.05% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PATH Analyst Recommendation Trends
Rating
Oct 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
2
2
1
0
1
Buy
1
3
3
2
2
Hold
25
37
25
18
21
Sell
0
1
1
1
2
Strong Sell
0
0
0
0
0
total
28
43
30
21
26
Each month's total comprises the sum of three months' worth of ratings.
PATH Financial Forecast
PATH Stock Forecast FAQ
What is PATH’s average 12-month price target, according to analysts?
Based on analyst ratings, Uipath Inc’s 12-month average price target is $12.03.
What is PATH’s upside potential, based on the analysts’ average price target?
Uipath Inc has 11.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PATH a Buy, Sell or Hold?
Uipath Inc has a consensus rating of Hold which is based on 3 buy ratings, 16 hold ratings and 2 sell ratings.
What is Uipath Inc’s price target?
The average price target for Uipath Inc is $12.03. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $15.00 ,the lowest forecast is $10.00. The average price target represents 11.29% Increase from the current price of $10.81.
The highest analyst price target is $15.00 ,the lowest forecast is $10.00. The average price target represents 11.29% Increase from the current price of $10.81.
What do analysts say about Uipath Inc?
Uipath Inc’s analyst rating consensus is a Hold. This is based on the ratings of 21 Wall Streets Analysts.
How can I buy shares of PATH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.